Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
Oncology Today with Dr Neil Love
00:00
Choosing Between TROP2 ADCs Clinically
Hope and Sara compare efficacy, schedules, and toxicity profiles to individualize TROP2 ADC selection.
Play episode from 35:03
Transcript
